Taking people in SwitzerlandNo phase
Observes dissolving magnesium stents in people with coronary artery disease
Follows people with coronary artery disease treated with dissolving magnesium heart stents.
Plain-language title generated from the registry record
Registry title: Resorbable Magnesium Scaffolds Registry
Key facts
- Where
- Bern, Lausanne, and Olten, SwitzerlandSee the 3 sites
Where in Switzerland
- LindenhofspitalBern, SwitzerlandTaking people
- Centre Hospitalier Universitaire VaudoisLausanne, SwitzerlandTaking people
- Solothurner Spitäler AGOlten, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Biotronik AG
- Trial code
- NCT04679740
- Record updated
- 21 November 2025
- Original description
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).Read full original descriptionShow less
RMS (Resorbable Magnesium Scaffolds) Registry
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
Inclusion: According to the IFU.
Exclusion: According to the IFU.